Compare PLRX & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | SMBK |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 893.2M |
| IPO Year | 2020 | 2000 |
| Metric | PLRX | SMBK |
|---|---|---|
| Price | $1.11 | $52.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $2.67 | ★ $43.17 |
| AVG Volume (30 Days) | ★ 408.2K | 79.7K |
| Earning Date | 05-06-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | 29.97 | ★ 39.25 |
| EPS | N/A | ★ 1.77 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.59 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | ★ N/A | $29.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $33.01 |
| 52 Week High | $1.95 | $54.14 |
| Indicator | PLRX | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 48.64 | 59.04 |
| Support Level | $1.12 | $50.93 |
| Resistance Level | $1.26 | $53.71 |
| Average True Range (ATR) | 0.04 | 1.02 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 27.69 | 84.05 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.